TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15611509

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² intravenously over 30 minutes on days 1 and 8 and ISIS‐2503 6 mg/kg/d as a continuous intravenous infusion over 14 days of an every‐3‐weeks cycle
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Gemcitabine and ISIS‐2503 combination
Number of subjects: 48
Study: 11972979

Group type: EXPERIMENTAL
Intervention: Combined high-dose hepatitis A and B vaccine (0, 6 month schedule)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Twinrix (0, 1, 6 month schedule)
Number of subjects: 100
Study: 9831104

Group type: EXPERIMENTAL
Intervention: Preoperative endoscopic submucosal injection of CH-40 (group A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No staining (group B)
Number of subjects: 45
Study: 8744963

Group type: EXPERIMENTAL
Intervention: Intact word pairs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recombined word pairs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speeded relatedness judgment task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-modal presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit speeded recognition task
Number of subjects: 0
Study: 1693173

Group type: EXPERIMENTAL
Intervention: Inosine pranobex (1 g three times a day)
Number of subjects: 866

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 866

Group type: EXPERIMENTAL
Intervention: Inosine pranobex
Number of subjects: 866
Study: 6104083

Group type: EXPERIMENTAL
Intervention: 100 mg trimethoprim
Number of subjects: 279

Group type: COMPARATOR
Intervention: 100 mg trimethoprim combined with 500 mg sulphamethoxazole (co-trimoxazole)
Number of subjects: 279
Study: 30517888

Group type: EXPERIMENTAL
Intervention: weWomen intervention (culturally tailored for immigrant and refugee women)
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: ourCircle intervention (culturally tailored for indigenous women)
Number of subjects: 1250

Group type: COMPARATOR
Intervention: usual safety planning control website
Number of subjects: 1250
Study: 29165775

Group type: EXPERIMENTAL
Intervention: Acute re-operation predictive index-intra-abdominal pressure (ARPI-IAP) model
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Logistic regression models developed in estimation group
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Validation of the ARPI-IAP model
Number of subjects: 300
Study: 25801761

Group type: EXPERIMENTAL
Intervention: Sitaxentan (endothelin A antagonist)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 27
Study: 23480506

Group type: EXPERIMENTAL
Intervention: Nurse-led intensive educational programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine guidance (Control)
Number of subjects: 80
Study: 21385192

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg b.d. for 12 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg b.d. for 12 months
Number of subjects: 77
Study: 19109804

Group type: EXPERIMENTAL
Intervention: Intervention to promote breast cancer screening
Number of subjects: 0
Study: 16567151

Group type: EXPERIMENTAL
Intervention: Semisolid yogurt (378 g)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Liquid yogurt (378 g)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Peach-flavored dairy beverage (400 mL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Peach juice beverage (400 mL)
Number of subjects: 32
Study: 12735507

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical prostatectomy
Number of subjects: 0
Study: 10717010

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg twice daily for 16 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg per day for 16 weeks, open-label phase)
Number of subjects: 55
Study: 2062329

Group type: EXPERIMENTAL
Intervention: 600 micrograms of inhaled budesonide twice a day
Number of subjects: 103

Group type: COMPARATOR
Intervention: 375 micrograms of inhaled terbutaline twice a day
Number of subjects: 103
Study: 6314720

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid (Vicryl)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Polyglactin 910 (Dexon)
Number of subjects: 306
Study: 31476447

Group type: EXPERIMENTAL
Intervention: Positive outcomes presented to participants in the intervention group (n = 48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Neutral outcomes presented to the control group (n = 50)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Anticipation of positive outcomes
Number of subjects: 98
Study: 29964041

Group type: EXPERIMENTAL
Intervention: Prebiotic supplement (2.8 g/d Bimuno containing 1.37 g beta-galactooligosaccharide) plus placebo (Mediterranean-type diet)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo supplement (2.8 g xylose) plus low-FODMAP diet
Number of subjects: 40
Study: 26043651

Group type: EXPERIMENTAL
Intervention: High insertion torque (≥50 Ncm)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Regular insertion torque (<50 Ncm)
Number of subjects: 116
Study: 24918721

Group type: EXPERIMENTAL
Intervention: Topical policresulen + cinchocaine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (usual guidelines with oral medications)
Number of subjects: 43
Study: 22789662

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 38
Study: 19660392

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Diagnostic tests (exercise treadmill test, exercise thallium scintigraphy, coronary computed tomography)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Follow-up of patients undergoing coronary revascularization
Number of subjects: 214
Study: 18241645

Group type: EXPERIMENTAL
Intervention: Danning Tablet (DNT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 135
Study: 16048421

Group type: EXPERIMENTAL
Intervention: Resistance training group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Aerobic training group
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 33
Study: 12209517

Group type: EXPERIMENTAL
Intervention: Low-dose IV CYC (500 mg, 6 fortnightly pulses) followed by AZA
Number of subjects: 90

Group type: COMPARATOR
Intervention: High-dose IV CYC (6 monthly pulses and 2 quarterly pulses, doses increased according to WBC count) followed by AZA
Number of subjects: 90
Study: 10828561

Group type: EXPERIMENTAL
Intervention: Novoste Beta‐Cath System with 90Sr/Y
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Guidant Intimal Hyperplasia Inhibition with Beta In‐stent Trial (INHIBIT) using 32P
Number of subjects: 42
Study: 8955439

Group type: EXPERIMENTAL
Intervention: Ketamine (65 mg/kg/day, adjusted as needed)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Midazolam (6.5 mg/kg/day) or Fentanyl (65 micrograms/kg/day)
Number of subjects: 35
Study: 2392914

Group type: EXPERIMENTAL
Intervention: 15‐propionat‐PGF2 alpha‐isopropylester (15‐prop‐PGF2 alpha‐IE)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PGF2 alpha‐isopropylester (PGF2 alpha‐IE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6508006

Group type: EXPERIMENTAL
Intervention: 2IRZ/4I2R2
Number of subjects: 213

Group type: COMPARATOR
Intervention: 2IRSZ/4I2R2
Number of subjects: 213
Study: 30709605

Group type: EXPERIMENTAL
Intervention: iTClamp
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Balloon Catheter Tamponade (BCT)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Direct Manual Pressure (DMP)
Number of subjects: 1
Study: 30203775

Group type: EXPERIMENTAL
Intervention: Gatifloxacin eye drops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levofloxacin eye drops
Number of subjects: 0
Study: 27009149

Group type: EXPERIMENTAL
Intervention: Asthma-tailored pulmonary rehabilitation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 25063793

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg once daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: GTN (0.6 mg/h, 2 h/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 23223178

Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 303
Study: 20068373

Group type: EXPERIMENTAL
Intervention: Farmers
Number of subjects: 392

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 392
Study: 17999973

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 121
Study: 16869933

Group type: EXPERIMENTAL
Intervention: Low-intensity warfarin
Number of subjects: 508
Study: 14663405

Group type: EXPERIMENTAL
Intervention: IPOM (Gore‐Tex DualMesh Plus biomaterial with holes Corduroy)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open tension free (patch and plug technique with Marlex prosthesis)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: IPOM
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open tension free
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 10651696

Group type: EXPERIMENTAL
Intervention: Interactive computer-assisted learning (CAL)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Non-interactive computer-assisted learning (CAL)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 227
Study: 8889412

Group type: EXPERIMENTAL
Intervention: Fentanyl (50 micrograms delivered as a bolus via an infusion pump) in 10 degrees C water condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fentanyl (50 micrograms delivered as a bolus via an infusion pump) in 2 degrees C water condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fentanyl (50 micrograms delivered as a bolus via an infusion pump) in 37 degrees C water condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subjective effects of fentanyl
Number of subjects: 10
Study: 2053453

Group type: EXPERIMENTAL
Intervention: 1200 mg of elemental calcium supplementation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 6313594

Group type: EXPERIMENTAL
Intervention: Acyclovir (5 mg/kg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Acyclovir (oral)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 30723975

Group type: EXPERIMENTAL
Intervention: Extended haemodialysis hours (median 24 h/week)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard haemodialysis hours (median 12 h/week)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Caregivers
Number of subjects: 54
Study: 28742609

Group type: EXPERIMENTAL
Intervention: Dynamic contract-relax stretching (DS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Static stretching (SS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study: 26930571

Group type: EXPERIMENTAL
Intervention: Immediate ART initiation (early group)
Number of subjects: 816

Group type: COMPARATOR
Intervention: Delayed ART initiation (delayed group)
Number of subjects: 816
Study: 24930168

Group type: EXPERIMENTAL
Intervention: Late verbal task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous verbal task
Number of subjects: 0

Group type: COMPARATOR
Intervention: No verbal task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Passive radio task
Number of subjects: 0
Study: 21637192

Group type: EXPERIMENTAL
Intervention: Back-up ventilation rate of 30 min(‐1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Back-up ventilation rate of 40 min(‐1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Back-up ventilation rate of 50 min(‐1)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Back-up ventilation rates of 30, 40, and 50 min(‐1)
Number of subjects: 26
Study: 20705381

Group type: EXPERIMENTAL
Intervention: Transumbilical port
Number of subjects: 50
Study: 17653075

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 68
Study: 15896247

Group type: COMPARATOR
Intervention: Mefloquine alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mefloquine co-administered with ketoconazole (400 mg/day for 10 days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mefloquine carboxylic acid metabolite
Number of subjects: 8
Study: 12010667

Group type: EXPERIMENTAL
Intervention: High-dose UFH (12,500 IU for one week followed by 10,000 IU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-dose UFH (5,000 IU)
Number of subjects: 60
Study: 10333394

Group type: EXPERIMENTAL
Intervention: Intubation (group I)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Nonintubation (group II)
Number of subjects: 169
Study: 7644088

Group type: EXPERIMENTAL
Intervention: Ketanserin 20-40 mg bid for three weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Enalapril 10-20 mg bid for three weeks
Number of subjects: 19
Study: 2655462

Group type: EXPERIMENTAL
Intervention: 40 mg of sodium fluoride daily
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 738077

Group type: EXPERIMENTAL
Intervention: Stomahesive adhesive plaster
Number of subjects: 30

Group type: COMPARATOR
Intervention: Other adhesive plasters
Number of subjects: 30
Study: 31820274

Group type: EXPERIMENTAL
Intervention: Dalfampridine 10 mg twice daily for 12 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 31486004

Group type: EXPERIMENTAL
Intervention: LifeSource UA-789AC monitor
Number of subjects: 167

Group type: COMPARATOR
Intervention: mercury sphygmomanometer
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: calibrated NYC HANES 2013-2014 blood pressure data
Number of subjects: 167
Study: 25787999

Group type: EXPERIMENTAL
Intervention: Mild emotional stressor
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no emotional stressor)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Parental feeding practices (reward and restriction)
Number of subjects: 41
Study: 23500313

Group type: EXPERIMENTAL
Intervention: Increase in hemoglobin concentration during hospitalization
Number of subjects: 1969

Group type: EXPERIMENTAL
Intervention: Baseline hemoglobin levels
Number of subjects: 1969

Group type: EXPERIMENTAL
Intervention: Total dose of diuretics
Number of subjects: 1969

Group type: EXPERIMENTAL
Intervention: Weight loss and baseline renal function
Number of subjects: 1969

Group type: EXPERIMENTAL
Intervention: Deterioration of renal function
Number of subjects: 1969
Study: 23525022

Group type: EXPERIMENTAL
Intervention: Single elbow crutch with conventional exercises for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Walker with conventional exercises for 6 weeks
Number of subjects: 40
Study: 19567768

Group type: EXPERIMENTAL
Intervention: Women with MRKH
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group women
Number of subjects: 66
Study: 16634952

Group type: EXPERIMENTAL
Intervention: High responders (HR)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low responders (LR)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Comparison of HR and LR
Number of subjects: 96
Study: 12632341

Group type: EXPERIMENTAL
Intervention: Standard-dose cisplatin-based chemotherapy (PEB)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: High-dose cisplatin-based chemotherapy (HDPEB)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall treatment (both groups)
Number of subjects: 25
Study: 10784332

Group type: EXPERIMENTAL
Intervention: Two Striper micron finishing system (MFS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sof-Lex XT (Sof-Lex)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Enhance composite finishing and polishing system (Enhance)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Shofu composite finishing kit (Shofu)
Number of subjects: 80
Study: 8769183

Group type: EXPERIMENTAL
Intervention: Neoral (cyclosporine microemulsion)
Number of subjects: 0
Study: 1567489

Group type: EXPERIMENTAL
Intervention: Electronic dolorimeter
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional ARA joint tenderness counts
Number of subjects: 30
Study: 3893385

Group type: EXPERIMENTAL
Intervention: Low intensity direct current (LIDC) protocol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional wound therapy
Number of subjects: 30
Study: 31869430

Group type: EXPERIMENTAL
Intervention: Glyburide (GLY)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Glyburide/Metformin combination therapy (COMBO)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Metformin (MET) and Glyburide/Metformin combination therapy (COMBO)
Number of subjects: 108
Study: 30074649

Group type: EXPERIMENTAL
Intervention: Exercise-based group (intervention)
Number of subjects: 150
Study: 27733219

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided TAP block with 0.5% ropivacaine 20 ml at 30 minutes before surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: TAP sham block with normal saline
Number of subjects: 80
Study: 24534763

Group type: EXPERIMENTAL
Intervention: Agalsidase alfa
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Agalsidase beta
Number of subjects: 362

Group type: COMPARATOR
Intervention: Cohort 1a (previously treated with ERT)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Cohort 1b (newly started on ERT)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Cohort 1c (not initially treated with ERT)
Number of subjects: 362
Study: 22435844

Group type: EXPERIMENTAL
Intervention: Implementation intentions to associate women with science in Expt 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation intentions to associate women with superordinate positions in Expt 4
Number of subjects: 0

Group type: COMPARATOR
Intervention: Egalitarian goal intentions in Expt 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation intentions in Expt 3
Number of subjects: 0
Study: 20642294

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg) therapy
Number of subjects: 260
Study: 18564806

Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask Airway (ILMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Direct Laryngoscopy
Number of subjects: 60
Study: 15327929

Group type: EXPERIMENTAL
Intervention: Double visual stimuli (white)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Monochromatic purple stimuli
Number of subjects: 2

Group type: COMPARATOR
Intervention: Monochromatic red stimuli
Number of subjects: 2
Study: 10957661

Group type: COMPARATOR
Intervention: Subcutaneous heparin injections (HEP group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Thigh-length sequential EPC device (EPC group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both subcutaneous heparin injections and EPC device (HEP + EPC group)
Number of subjects: 48
Study: 9285071

Group type: EXPERIMENTAL
Intervention: B13/L2 supplementation (13 mg beta-carotene, 2 mg lycopene, 5 mg vitamin E, 30 mg vitamin C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: B3/L3 supplementation (3 mg beta-carotene, 3 mg lycopene, 5 mg vitamin E, 30 mg vitamin C)
Number of subjects: 20
Study: 8333483

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 101

Group type: COMPARATOR
Intervention: Magnesium sulfate
Number of subjects: 101
Study: 3553031

Group type: EXPERIMENTAL
Intervention: High-molecular-weight, formalinized allergoid
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 31881459

Group type: EXPERIMENTAL
Intervention: Prenatal individualized mixed management intervention (4 sessions)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 182
Study: 29868830

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 823

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 823
Study: 26851201

Group type: EXPERIMENTAL
Intervention: Rotigotine (1-3mg/24 h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 25008439

Group type: EXPERIMENTAL
Intervention: Topical 5% 5-fluorouracil (5-FU)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 99
Study: 22710564

Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy
Number of subjects: 148

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 148
Study: 20170481

Group type: EXPERIMENTAL
Intervention: Removable dental prostheses for molar replacement (treatment A)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Fixed bridges for replacement of all missing anterior and premolar teeth (treatment B)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Both treatments A and B
Number of subjects: 215
Study: 18498925

Group type: EXPERIMENTAL
Intervention: Erlotinib added to gemcitabine treatment regimen for 40% (n=10) of gemcitabine-treated patients for 15.7 weeks of therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Gemcitabine alone
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Erlotinib added to gemcitabine treatment regimen
Number of subjects: 43
Study: 15791818

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letrozole vs Tamoxifen
Number of subjects: 0
Study: 12525801

Group type: EXPERIMENTAL
Intervention: Nutrition intervention program based on Social Learning Theory emphasizing fruit exposure and positive parent-child feeding strategies
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (17 parent-child pairs who expressed interest but were unable to attend more than one session)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nutrition intervention program
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9
Study: 10813547

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid/cross-linked sodium carboxymethyl cellulose system with enteric-coated capsule
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional commercial ursodeoxycholic acid capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug/polymer system
Number of subjects: 0